Global Epigenetics Drugs & Diagnostic Technologies Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Product;

Reagents, Kits - ChIP Sequencing Kit, Whole Genomic Amplification Kit, Bisulfite Conversion Kit, RNA Sequencing Kit, and Others, Instruments, Enzymes, and Services.

By Technology;

DNA Methylation, Histone Methylation, Histone Acetylation, Large Non-coding RNA, MicroRNA Modification, and Chromatin Structures.

By Therapy;

Histone Deacetylase (HDAC) Inhibitors and DNA Methyltransferase (DNMT) Inhibitors.

By Application;

Oncology - Solid Tumors and Liquid Tumors, Non-oncology - Inflammatory Diseases, Metabolic Diseases, Infectious Diseases, Cardiovascular Diseases, and Others.

By End-Users;

Hospitals, Homecare, Specialty Clinics, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn990448827 Published Date: October, 2024 Updated Date: December, 2024
Download Free Sample NowDownload Free Sample Now

Introduction

Global Epigenetics Drugs & Diagnostic Technologies Market (USD Million), 2020 - 2030

In the year 2023, the Global Epigenetics Drugs & Diagnostic Technologies Market was valued at USD 8,780.61 million. The size of this market is expected to increase to USD 22,242.70 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 14.2%.

The growing prevalence of cancer and chronic diseases, combined with an increasing geriatric population, is expected to drive significant growth in the epigenetics market. Key organizations, such as the International Human Epigenome Consortium (IHEC), the National Cancer Institute (NCI), and the National Institutes of Health (NIH), actively support research and development (R&D) efforts by providing funding and resources. These initiatives are anticipated to accelerate the development of innovative products and therapeutic solutions in the field of epigenetics.

The NIH, through its Common Fund Epigenomics program, plays a pivotal role in promoting epigenetic research globally. This program provides vital financial backing for studies that explore molecular-level epigenetic modifications and aim to develop targeted therapies. Additionally, initiatives like the Epidemiology and Genomics Research Program (EGRP) under the NCI's Division of Cancer offer grants for novel epigenetic research, further propelling advancements in the market by fostering scientific breakthroughs.

International collaborations also contribute to the growth of epigenetics research. The International Cancer Genome Consortium (ICGC) focuses on analyzing genomic, epigenomic, and transcriptomic changes across various tumor types to improve cancer treatment. Similarly, the U.S. National Human Genome Research Institute launched the Encyclopedia of DNA Elements (ENCODE) project to identify all functional elements of the human genome. The IHEC, supported by the NIH, is actively involved in data generation and analysis to benefit epigenomic research. Much of the current research in epigenetics centers on identifying new treatment options for different types of cancer, underscoring the importance of these global efforts in driving market expansion.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Region
    3. Market Opportunity Map
  4. Global Epigenetics Drugs & Diagnostic Technologies Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Epigenetics Drugs & Diagnostic Technologies Market, By Type, 2022- 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Epigenetic Drugs
          1. Introduction
          2. Market Share Analysis, 2024 and 2030 (%)
          3. Y-o-Y Growth Analysis, 2021 - 2030
          4. Segment Trends
            1. DNMT Inhibitors
              1. Introduction
              2. Market Share Analysis, 2024 and 2030 (%)
              3. Y-o-Y Growth Analysis, 2021 - 2030
              4. Segment Trends
                1. Azacitidine
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
                2. Decitabine
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            2. HDAC Inhibitors
              1. Introduction
              2. Market Share Analysis, 2024 and 2030 (%)
              3. Y-o-Y Growth Analysis, 2021 - 2030
              4. Segment Trends
                1. Vorinostat
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
                2. Romidepsin
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Epigenetics Diagnostic Technologies
          1. Introduction
          2. Market Share Analysis, 2024 and 2030 (%)
          3. Y-o-Y Growth Analysis, 2021 - 2030
          4. Segment Trends
            1. DNA Methylation
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            2. ChIP Technology
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Global Epigenetics Drugs & Diagnostic Technologies Market, By Geography, 2022- 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
        4. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
        5. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. 4SC AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Acetylon Pharmaceuticals, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Astex Pharmaceuticals Inc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. CellCentric Ltd
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Celleron Therapeutics Ltd.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Celgene Corporation
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Base Genomics
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Oryzon Genomics, S.A
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market
Download Free Sample NowDownload Free Sample Now